Watson Pharmaceuticals, Inc. announced Tuesday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the U.S. is being voluntarily recalled from wholesalers and pharmacies. The recalled patches are from Lot Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. The affected lot of Fentanyl Transdermal System patches was shipped to customers between April 2, 2009 and May 20, 2009. No other s...
Read more »...someone get off pain medications because it reduces withdrawal symptoms, cravings, and the risk... Read more »
...Cannabinoids also appear to enhance the effects of opiate pain medications to provide pain... Read more »
Within the pain medication family of opiates is methadone. However, even though methadone is an... Read more »
The FDA has a very tough job. With respect to medicines, they require and examine documents that... Read more »
...addition, cannabinoids appear to increase the effects of opiate pain medications, allowing for... Read more »
...is a long-acting form of a narcotic pain reliever (opiate-type). It acts on certain centers in... Read more »
(Ivanhoe Newswire) -- Nicotine addiction has reached its highest level within the last 15 years. Almost 75 percent of people currently being treated... Read summary »
(Ivanhoe Newswire) ? Doctors who really want to help their patients kick the habit need to get aggressive. That's the take home message from two... Read summary »
Women who quit smoking have more intense withdrawal symptoms than men, a new study suggests. Researchers did not determine if women were less likely... Read summary »
Some patients are finding that tapering off antidepressants like Paxil, Effexor, and Zoloft does not keep them from suffering difficult physical... Read summary »
A reader gives other People's Pharmacy readers cautionary advice about skipping doses of Effexor. After missing only a few doses of the... Read summary »